Parabilis Medicines, Inc. (PBLS)
About Parabilis Medicines, Inc.
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $3.8B
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.8B
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 10, 2026
Parabilis Medicines, Inc. (PBLS) Stock Price
- Trading 5% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Parabilis Medicines, Inc..
Write a review
News about Parabilis Medicines, Inc.
News & sentiment via Polygon.io
Parabilis Medicines, Inc.: frequently asked questions
Is Parabilis Medicines, Inc. an American company?
Parabilis Medicines, Inc. is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Parabilis Medicines, Inc. headquartered?
Parabilis Medicines, Inc. is headquartered in Cambridge, Massachusetts, United States.
Is Parabilis Medicines, Inc. publicly traded?
Yes — Parabilis Medicines, Inc. is a publicly traded company. Its stock trades under the ticker symbol PBLS.
What does Parabilis Medicines, Inc. do?
Parabilis Medicines, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
